125 related articles for article (PubMed ID: 8391832)
1. An update of the medical treatment of malignant endocrine pancreatic tumors.
Eriksson B; Oberg K
Acta Oncol; 1993; 32(2):203-8. PubMed ID: 8391832
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors.
Eriksson B; Skogseid B; Lundqvist G; Wide L; Wilander E; Oberg K
Cancer; 1990 May; 65(9):1883-90. PubMed ID: 1695540
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of neuroendocrine gut and pancreatic tumors.
Oberg K; Eriksson B
Acta Oncol; 1989; 28(3):425-31. PubMed ID: 2472826
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.
Fjällskog ML; Sundin A; Westlin JE; Oberg K; Janson ET; Eriksson B
Med Oncol; 2002; 19(1):35-42. PubMed ID: 12025889
[TBL] [Abstract][Full Text] [Related]
5. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
Frank M; Klose KJ; Wied M; Ishaque N; Schade-Brittinger C; Arnold R
Am J Gastroenterol; 1999 May; 94(5):1381-7. PubMed ID: 10235222
[TBL] [Abstract][Full Text] [Related]
7. [Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report].
Congy F; Pelletier S; Langlois P; Khayat D; Homsi T; Emerit J
Rev Med Interne; 1992 Nov; 13(6):451-3. PubMed ID: 1285358
[TBL] [Abstract][Full Text] [Related]
8. Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.
Oberg K; Eriksson B; Janson ET
Digestion; 1994; 55 Suppl 3():64-9. PubMed ID: 7698540
[TBL] [Abstract][Full Text] [Related]
9. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
Moertel CG; Hanley JA; Johnson LA
N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
[TBL] [Abstract][Full Text] [Related]
10. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy.
Strosberg J; Hoffe S; Gardner N; Choi J; Kvols L
Neuroendocrinology; 2007; 85(4):216-20. PubMed ID: 17541257
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
[TBL] [Abstract][Full Text] [Related]
12. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
Flückiger A; Schlup P
Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
[TBL] [Abstract][Full Text] [Related]
13. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
[TBL] [Abstract][Full Text] [Related]
14. [Vipoma. 9-year observations using currently available therapy methods].
Zimmermann K; Rapp T; Binder J; Frölich J; Bode JC
Dtsch Med Wochenschr; 1986 Feb; 111(8):298-301. PubMed ID: 2868874
[TBL] [Abstract][Full Text] [Related]
15. Octreotide--a synthetic somatostatin.
Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
[No Abstract] [Full Text] [Related]
16. Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors.
Zilembo N; Buzzoni R; Bajetta E; Di Bartolomeo M; de Braud F; Castellani R; Maffioli L; Celio L; Villa E; Lorusso V
Acta Oncol; 1993; 32(2):245-50. PubMed ID: 8391833
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
Arnold R; Neuhaus C; Trautmann ME
Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
[No Abstract] [Full Text] [Related]
19. A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Saltz L; Kemeny N; Schwartz G; Kelsen D
Cancer; 1994 Aug; 74(3):958-61. PubMed ID: 8039124
[TBL] [Abstract][Full Text] [Related]
20. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]